Paper39202022
Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia.
Mavridou D and 2 others. J Pers Med, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia. Papers, record 39202022. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39202022
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26643954 | Metabolism pathways in chronic lymphocytic leukemia. | Leuk Lymphoma | 2016 | https://conductscience.org/library/papers/26643954 | PubMed |
| 2 | 26288427 | Vorinostat-An Overview. | Indian J Dermatol | 2015 | https://conductscience.org/library/papers/26288427 | PubMed |
| 3 | 25642308 | A review of arsenic trioxide and acute promyelocytic leukemia. | Int J Hematol Oncol Stem Cell Res | 2014 | https://conductscience.org/library/papers/25642308 | PubMed |
| 4 | 38404932 | Proteomics and Its Current Application in Biomedical Area: Concise Review. | ScientificWorldJournal | 2024 | https://conductscience.org/library/papers/38404932 | PubMed |
| 5 | 36370099 | The ProteomeXchange consortium at 10 years: 2023 update. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36370099 | PubMed |
| 6 | 34631760 | Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34631760 | PubMed |
| 7 | 35732829 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732829 | PubMed |
| 8 | 37568720 | Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37568720 | PubMed |
| 9 | 27903968 | Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling. | Oncotarget | 2017 | https://conductscience.org/library/papers/27903968 | PubMed |
| 10 | 29497278 | Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/29497278 | PubMed |
| 11 | 31715423 | Molecular insight of regorafenib treatment for colorectal cancer. | Cancer Treat Rev | 2019 | https://conductscience.org/library/papers/31715423 | PubMed |
| 12 | 25838395 | Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25838395 | PubMed |
| 13 | 24870543 | Mass-spectrometry-based draft of the human proteome. | Nature | 2014 | https://conductscience.org/library/papers/24870543 | PubMed |
| 14 | 36304921 | Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36304921 | PubMed |
| 15 | 36349817 | Mass spectrometry-based high-throughput proteomics and its role in biomedical studies and systems biology. | Proteomics | 2023 | https://conductscience.org/library/papers/36349817 | PubMed |
| 16 | 36333502 | Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. | Nat Genet | 2022 | https://conductscience.org/library/papers/36333502 | PubMed |
| 17 | 34339852 | Decoding Post-Translational Modification Crosstalk With Proteomics. | Mol Cell Proteomics | 2021 | https://conductscience.org/library/papers/34339852 | PubMed |
| 18 | 26262627 | Eribulin in Cancer Treatment. | Mar Drugs | 2015 | https://conductscience.org/library/papers/26262627 | PubMed |
| 19 | 28073159 | Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. | Hepatology | 2017 | https://conductscience.org/library/papers/28073159 | PubMed |
| 20 | 18925949 | BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. | BMC Genomics | 2008 | https://conductscience.org/library/papers/18925949 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42104236 | Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia. | Clin Proteomics | 2026 | https://conductscience.org/library/papers/42104236 | PubMed |
| 41893727 | Proteomic Analysis in Search of New Biomarkers of Immune Thrombocytopenia (ITP)-A Review of Current Data. | Proteomes | 2026 | https://conductscience.org/library/papers/41893727 | PubMed |
| 40559994 | Oxidative Stress and Its Role in the Emergence and Progression of Myelodysplastic Syndromes: Insights from Proteomic Analysis and Other Methodologies. | Proteomes | 2025 | https://conductscience.org/library/papers/40559994 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PIGR | 5284 | PubTator's text mining | https://conductscience.org/library/genes/5284 | NCBI Gene |
| SNRPA | 6626 | PubTator's text mining | https://conductscience.org/library/genes/6626 | NCBI Gene |
| YEATS2 | 55689 | PubTator's text mining | https://conductscience.org/library/genes/55689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39202022
GET https://conductscience.org/api/papers/v1/39202022/references?page=2